Sat.Apr 29, 2023 - Fri.May 05, 2023

article thumbnail

Advice For New Pharmacists: Lessons Form The Front Lines

IDStewardship

In this article advice for new pharmacists is provided by a pharmacist with 15 years of experience and answers are sourced from commentary on Twitter as well. Composed By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 1 May 2023 Recently while attending the American Pharmacist Association’s annual meeting in Phoenix, AZ I walked by a grown man at a breakfast bar wearing a head-to-toe onesie patterned with Dunkin’ Doughnuts (DD) logos.

article thumbnail

Breaking: FDA Approves First-Ever RSV Vaccine

Drug Topics

The vaccine is approved for use in adults aged 60 and older to prevent lower respiratory tract disease caused by RSV.

Vaccines 469
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharmacists Find Marketing Success With Instagram, TikTok

Drug Topics

Pharmacists can reach the members of their community through creative use of social media platforms such as Instagram and TikTok.

468
468
article thumbnail

New PhRMA Ad Campaign Sheds Light on PBM Abuses

PhRMA

The Pharmaceutical Research and Manufacturers of America (PhRMA) today launched a new ad campaign that continues to shed light on the role of pharmacy benefit managers (PBMs) in driving up health care costs and denying coverage of lifesaving medicines.

322
322
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

A CEO’s quest to solve a 400-year-old medical mystery — and he’s also a patient

PharmaVoice

The CEO of Ventoux Biosciences has the disease that his company is aiming to treat, and it's driving him to find better medications.

317
317
article thumbnail

Novavax’s COVID-19 Vaccine Demonstrates Efficacious, Safe Response in Adolescents

Pharmacy Times

Analysis shows that the ratio of neutralizing antibody geometric mean titers in adolescents compared with young adults was 1.5 after vaccination with NVX-CoV2373.

Vaccines 153

More Trending

article thumbnail

Americans want state policymakers to lower out-of-pocket costs

PhRMA

Too many Americans are struggling to access and afford their health care. While policy debates about how to address these issues can seem never ending, American adults largely agree on what state policymakers should be doing to help deliver relief to patients at the pharmacy counter.

307
307
article thumbnail

Taking your biotech global? Here’s how you can navigate cultural norms

PharmaVoice

What’s so different about doing pharma business in the U.K. versus Japan? One of Moderna’s top brass shares her tips for navigating choppy cultural waters.

264
264
article thumbnail

What explains rare heart condition among young men after Covid vaccines? A new study offers clues

STAT

A new study sheds light on what may be causing very rare cases of heart inflammation in young men after receiving an mRNA Covid vaccine. Early hypotheses as to what was driving the heart inflammation, called myocarditis , included an allergic response to the vaccine, vaccine-induced antibodies, or an autoimmune response in which the immune system attacks the body’s own healthy tissue by mistake.

Vaccines 145
article thumbnail

Pasteur Act Reintroduced in Congress

Drug Topics

Both Democrats and Republicans voted to bring back the act that attempts to improve use of antibiotics

469
469
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

4 Things to know about PhRMA’s new 50-state poll

PhRMA

When it comes to health care, Americans are concerned about innovation and affordability.

Insurance 282
article thumbnail

Emalex aims at a first-in-class breakthrough for Tourette syndrome

PharmaVoice

With its phase 3 candidate, the biotech believes it can move the field beyond antipsychotics to a more effective approach.

260
260
article thumbnail

AI, Machine Learning Improve Patient Care, Can Empower Health Care Professionals

Pharmacy Times

There are still significant unresolved issues in artificial intelligence and machine learning, which must be addressed before they can be safely and effectively used more broadly in medicine.

article thumbnail

Risk Factors Associated with TRD

Drug Topics

Medical experts discuss the risk factors associated with TRD.

468
468
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

New resource underscores the importance of small molecule medicines

PhRMA

A small molecule medicine is what most people think of when they imagine a medicine. These medicines typically come in the form of a tablet or capsule and are usually taken by mouth. These medicines play essential roles in the treatment of different diseases and are indispensable in providing patients, caregivers and health care providers with the tools necessary to achieve improved health outcomes.

252
252
article thumbnail

From science to strategy, this exec is painting Genmab’s bigger picture into the next decade

PharmaVoice

Martine van Vugt, recently named Genmab’s chief strategy officer and executive vice president, aims to usher in the company’s next wave of "knock your socks off" antibodies.

242
242
article thumbnail

For Eli Lilly’s head scientist, Alzheimer’s results cap a 25-year scientific quest

STAT

If you flip to the 1,031st page of the May 1998 edition of the Journal of Cell Biology, you’ll find the first scientific byline for Daniel Skovronsky, then a young trainee at the University of Pennsylvania, on an article describing how beta-amyloid, a vexing molecule thought to play a role in Alzheimer’s disease, was more complicated than the field understood.

139
139
article thumbnail

How Each COVID-19 Variant Impacts Children Differently

Drug Topics

Though the Omicron variant caused the most symptoms in pediatric patients, there were no differences in adverse outcomes by COVID-19 variant.

467
467
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Combination CRISPR, Antiretroviral Therapies Could Eliminate 100% of HIV

Pharmacy Times

At least 58% of mice treated with combined CRISPR therapies showed signs of complete HIV-1 viral elimination.

139
139
article thumbnail

Attracting up-and-coming talent in biotech

PharmaVoice

The CEO of a Bay-area startup shares his strategies for growing a team from the ground up.

241
241
article thumbnail

Verizon will supply VA with mobile devices, emergency tech in $448M deal

Fierce Healthcare

Verizon will supply VA with mobile devices, emergency tech in $448M deal aburky Fri, 05/05/2023 - 16:17

131
131
article thumbnail

Treatment Landscape Surrounding TRD

Drug Topics

Key opinion leaders illustrate treatment strategies for patients diagnosed with TRD.

465
465
article thumbnail

The Role of the Pharmacy Technician Expands into Pharmacy-Based Community Health Worker

Pharmacy Times

The advent of pharmacy-based community health workers has helped to expand and codify the pre-existing community-based efforts of pharmacy technicians to reach even outside of medication access.

132
132
article thumbnail

A biopharma CEO opens up about executive salaries — and why he wants to change the status quo

PharmaVoice

With leaders at the biggest biopharma companies bringing in millions, the CEO of Corvus Pharmaceuticals opted for a pay cut to pour more funds into science.

147
147
article thumbnail

CDC to cut back on Covid data it collects as public health emergency ends

STAT

The ending of the public health emergency for Covid-19 will force the Centers for Disease Control and Prevention to cut back on the data it collects to analyze how much illness the SARS-CoV-2 virus is causing in the future, the CDC announced Friday. But some of the data metrics the CDC will no longer be able to collect are of lesser value now than they were at earlier points in the pandemic, agency officials explained in a press briefing Thursday in advance of Friday’s release of two arti

129
129
article thumbnail

Data, Collaboration Can Help Unlock the Full Potential of Value-Based Care

Drug Topics

A unified data ecosystem will provide the foundation for the next generation of patient-care technology.

article thumbnail

Consider Real-World Barriers When Deciding on Treatment for Diabetic Macular Edema

Pharmacy Times

Pharmacists will play a growing role in the use of biosimilars and guiding patients through the switching process.

132
132
article thumbnail

How Immunocore’s Bahija Jalla embraced the ‘a-ha’ moment of promising science

PharmaVoice

The biotech CEO is bullish on the company’s pioneering T cell receptor platform and innovating new immunology-based treatments.

130
130
article thumbnail

CVS closes $10.6B acquisition of Oak Street Health to expand primary care footprint

Fierce Healthcare

CVS closes $10.

129
129
article thumbnail

Can AI Answer Patients' Questions Better Than Professionals?

Drug Topics

A new study investigates whether GPT-4 can provide more in-depth analysis than medical professionals.

266
266
article thumbnail

Pharmacists Are Vital to Transitions of Care

Pharmacy Times

Clinical interventions, follow-ups, medication reconciliation, patient education are key aspects of the programs.

132
132
article thumbnail

Navigating workforce challenges amid a turbulent biopharma market

PharmaVoice

A number of biopharma companies slashed their workforces this year and as market anxieties persist, more challenges could be looming.

130
130
article thumbnail

Roche opens new institute to advance research in human model systems

Pharmaceutical Technology

Roche has opened a new institute to accelerate research and development (R&D) in the area of human model systems such as organoids. Situated in Basel, Switzerland, the newly launched Institute of Human Biology (IHB) will accommodate scientists and bioengineers from academia and the pharmaceutical sector. Researchers at IHB will study human biology and speed up the adoption of human model systems in pharmaceutical R&D in addition to clinical practice.